Biotech · Public company · Durham, NC, US
Immunovant, Inc.
Ticker IMVT · SEC CIK 0001764013
Track this companyFree. Adds Immunovant, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availableNo recent cash burn filed
SEC filings12
- 10-Q · 10-QSEC EDGAR · filed Nov 9, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 9, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Sep 3, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Aug 6, 2026 · fetched Nov 12, 2026
- 10-K · 10-KSEC EDGAR · filed May 20, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed May 20, 2026 · fetched Nov 12, 2026
- 10-Q · 10-QSEC EDGAR · filed Feb 6, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Feb 6, 2026 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Dec 12, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Dec 11, 2025 · fetched Nov 12, 2026
- 8-K · 8-KSEC EDGAR · filed Nov 21, 2025 · fetched Nov 12, 2026